CervoMed Inc. (CRVO)
NASDAQ: CRVO
· Real-Time Price · USD
10.17
-0.02 (-0.20%)
At close: Aug 15, 2025, 3:59 PM
10.11
-0.59%
After-hours: Aug 15, 2025, 05:20 PM EDT
CervoMed Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -6.26M | -4.89M | -6.71M | -9.62M | -2.32M | -2.51M | -2.36M | 2.15M | -2.11M | -4.09M | -4.08M | -2.8M | -4.19M | -4.53M | -3.47M | -12.2M | -3.78M | -4.64M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 26.11K | 19.1K | 23.75K | 24.45K |
Stock-Based Compensation | 497.01K | 361.17K | 337.71K | 1.01M | 578.58K | 218.22K | 164.97K | 109.17K | 110.8K | 71.24K | 80.99K | 82.38K | n/a | n/a | n/a | n/a | 297.28K | 181.28K |
Other Working Capital | 289.67K | -83.83K | 261.36K | 19.29K | -418.9K | 187.44K | 23.53K | 279.66K | 72.46K | -655.12K | 352.48K | 178.73K | 377.88K | -495.9K | -129.92K | 171.99K | 126.61K | -417.68K |
Other Non-Cash Items | -234.67K | -251.83K | -383K | 2.6M | -338.21K | n/a | n/a | -1.17M | 716.51K | 362.2K | -43.19K | 349.53K | 687.04K | 236.44K | 111.65K | 8.17M | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -443.89K | n/a | n/a |
Change in Working Capital | -518.64K | 890.34K | -1.3M | 1.16M | -125.11K | 872.45K | -341.03K | 1.61M | -588.49K | -946.53K | 499.16K | -65.64K | -62.93K | -467.76K | 116.75K | 848.27K | 129.53K | -738.18K |
Operating Cash Flow | -6.51M | -3.89M | -8.05M | -4.85M | -2.2M | -1.42M | -2.54M | 2.7M | -2.65M | -4.97M | -3.47M | -2.76M | -4.01M | -4.73M | -3.03M | -2.97M | -3.33M | -5.18M |
Capital Expenditures | -5 | n/a | n/a | n/a | 5.00 | n/a | n/a | -5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4K | n/a | n/a | n/a |
Purchase of Investments | -9.75M | -7.1M | -3.63M | -3.9M | -40.57M | n/a | n/a | n/a | n/a | n/a | n/a | -6.37M | -8.9M | -22.72M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 9.5M | 12.5M | 12.94M | 3.5M | n/a | n/a | n/a | -12.5M | 3M | 9.5M | 7M | 9.75M | 9M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -254.99K | 5.4M | 9.31M | 2.6M | -40.57M | n/a | n/a | -12.5M | 3M | 9.5M | 7M | 3.38M | 100.59K | -22.72M | 4K | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 46.4M | n/a | n/a | n/a | -93.38K | 10.43M | n/a | n/a | n/a | -5K | n/a | n/a | n/a | n/a | n/a | 2.2M |
Financial Cash Flow | 4.59M | n/a | n/a | -13.34K | 46.41M | n/a | -93.38K | 11.24M | n/a | n/a | n/a | n/a | n/a | 5K | n/a | n/a | n/a | 33.3M |
Net Cash Flow | -2.18M | 1.5M | 1.26M | -2.27M | 3.64M | -1.42M | -2.63M | 9.77M | 353.96K | 4.53M | 3.53M | 621.29K | -3.91M | -27.44M | -3.02M | -2.97M | -3.33M | 28.12M |
Free Cash Flow | -6.51M | -3.89M | -8.05M | -8.09M | -2.2M | -1.42M | -2.54M | 2.7M | -2.65M | -4.97M | -3.47M | -2.76M | -4.01M | -4.73M | -3.03M | -2.97M | -3.33M | -5.18M |